PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Vinca alkaloids derived from the plant are used as anti-cancer agents in humans; specifically, vinflunine is used to treat transitional cell urothelial bladder cancer [PMID:32491774].
Methanolic whole plant extracts showed significant anti-hyperglycemic activity and regeneration of pancreatic beta-cells in alloxan-induced diabetic rats [PMID:20652054].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 32491774 (2026) — Imaging MS Analysis in Catharanthus roseus. · Methods in molecular biology (Clifton, N.J.)
- 2.PMID: 32303816 (2020) — Biotechnological advancements in Catharanthus roseus (L.) G. Don. · Applied microbiology and biotechnology
- 3.PMID: 38575897 (2024) — Catharanthus roseus intoxication mimicking acute cholangitis. · BMC complementary medicine and therapies
- 4.PMID: 30967897 (2019) — croFGD: Catharanthus roseus Functional Genomics Database. · Frontiers in genetics
- 5.PMID: 35333954 (2022) — Engineering Catharanthus roseus monoterpenoid indole alkaloid pathway in yeast. · Applied microbiology and biotechnology